Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06117254 · ClinicalTrials.gov registry record · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
A NA study of Auditory Processing Disorder, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 142
- Enrollment target
- 1
- Study location
NCT06117254: Recruiting NA study of Auditory Processing Disorder, sponsored by VA Office of Research and Development.
NCT06117254 is a NA study of Auditory Processing Disorder that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 142 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06117254, a NA study of Auditory Processing Disorder, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
- 1
- Study location
Study Summary
Every year, approximately 100,000 Veterans seek help at VA Audiology clinics for hearing and communication difficulties only to learn that they have normal hearing sensitivity. Unfortunately, there are very few established options to improve hearing and listening for these patients. To address this need, audiologists are increasingly prescribing hearing aids set to provide a small amount of amplification. Patients may benefit from the amplification or from modern hearing aid features such as noise reduction technology and the ability to stream sounds from a desired sound source directly to their ears thus reducing the background noise. This project will help to determine if prescribing hearing aids to patients without hearing loss is, in fact, beneficial and if so, why. It will also help to determine if some patients benefit more from hearing aids than others so that in the future, rehabilitation strategies can be better targeted toward individuals.
Primary Outcome
The HHIA is a self-report measure of the impact of hearing difficulties on daily life and functioning, including social and emotional affects. It is comprised of 25 questions with total scores from 0 to 100. Higher scores indicate greater levels of perceived hearing handicap.
Conditions Studied
Interventions
- BEHAVIORAL Communication Counseling
- DEVICE Hearing Aids
- DEVICE Remote Microphones
Study Locations (1)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2025-03-09 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06117254 shows while recruiting
NCT06117254 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Auditory Processing Disorder appearing as the primary indexed condition, and to 3 interventions - of which Communication Counseling is the first listed.
NCT06117254 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06117254 about?
NCT06117254 is a clinical study titled "Hearing Aids for Veterans With Functional Hearing Difficulties". Every year, approximately 100,000 Veterans seek help at VA Audiology clinics for hearing and communication difficulties only to learn that they have normal hearing sensitivity. Unfortunately, there are very few established options to improve hearing and listening for these patients. To address this ...
What is the current status of trial NCT06117254?
This trial is currently recruiting. It is a NA study. The enrollment target is 142 participants. The study started on 2025-03-09. Estimated completion is 2028-03-31.
What conditions does trial NCT06117254 study?
This clinical trial studies the following conditions: Auditory Processing Disorder.
What interventions are being tested in trial NCT06117254?
The interventions under investigation include: Communication Counseling (BEHAVIORAL), Hearing Aids (DEVICE), Remote Microphones (DEVICE).
Who is sponsoring clinical trial NCT06117254?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06117254 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06117254's enrollment target sits among peer trials
142 711th of 2000 higher than 1,289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
- NCT06524830 · 142 participants · Phase 2
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI